Start SIP in MEDPLUS
Start SIPPerformance
- Low
- ₹840
- High
- ₹867
- 52 Week Low
- ₹599
- 52 Week High
- ₹876
- Open Price₹864
- Previous Close₹865
- Volume213,547
Investment Returns
- Over 1 Month + 15.29%
- Over 3 Month + 27.03%
- Over 6 Month + 23.88%
- Over 1 Year + 13.62%
Smart Investing Starts Here Start SIP with Medplus Health Services for Steady Growth!
Medplus Health Services Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 101.3
- PEG Ratio
- 1.4
- Market Cap Cr
- 10,151
- P/B Ratio
- 6.4
- Average True Range
- 28.68
- EPS
- 8.38
- Dividend Yield
- 0
- MACD Signal
- 39.5
- RSI
- 64.22
- MFI
- 62.5
Medplus Health Services Financials
Medplus Health Services Technicals
EMA & SMA
Current Price
₹848.05
-17.3
(-2%)
- Bullish Moving Average 12
- Bearish Moving Average 4
- 20 Day
- ₹822.56
- 50 Day
- ₹765.66
- 100 Day
- ₹730.45
- 200 Day
- ₹717.52
Resistance and Support
851.75
- R3 890.10
- R2 878.55
- R1 863.30
- S1 836.50
- S2 824.95
- S3 809.70
Medplus Health Services Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-12 | Quarterly Results | |
2024-08-02 | Quarterly Results | |
2024-05-28 | Audited Results | |
2024-02-21 | Others | Inter alia, to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023. |
2024-02-02 | Quarterly Results |
Medplus Health Services F&O
About Medplus Health Services
- NSE Symbol
- MEDPLUS
- BSE Symbol
- 543427
- ISIN
- INE804L01022
Similar Stocks to Medplus Health Services
Medplus Health Services FAQs
Medplus Health Services share price is ₹848 As on 22 December, 2024 | 23:06
The Market Cap of Medplus Health Services is ₹10150.6 Cr As on 22 December, 2024 | 23:06
The P/E ratio of Medplus Health Services is 101.3 As on 22 December, 2024 | 23:06
The PB ratio of Medplus Health Services is 6.4 As on 22 December, 2024 | 23:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.